干眼症治疗市场规模、份额、成长分析、按类型、药物、产品、剂型、销售管道、地区 - 产业预测，2025-2032 年

2023 年全球干眼症治疗市场规模价值 70.7 亿美元，预计将从 2024 年的 75.6 亿美元增长到 2032 年的 130 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.0%。

由于干眼症盛行率上升和人口老化，全球干眼症治疗市场正在经历强劲增长。意识的增强、诊断工具的技术进步以及对患者舒适度的关注正在推动市场扩张。主要治疗选择是药物干预，如人工泪液、抗发炎药物和免疫调节剂。此外，再生医学和基因疗法等创新治疗方法也越来越受到青睐，有望解决干眼症的根本原因。随着研发的不断深入，市场将持续成长，提高治疗效果并改善病患的治疗效果。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析
• 贸易分析

干眼症治疗市场规模（按类型）

• 市场概况
• 蒸发性干眼症
• 泪液缺乏性干眼症

干眼症治疗市场规模（依药物类型）

• 市场概况
• 汐多拉
• 雷斯塔西斯
• 塞夸
• 蒂亚
• 阿塞维斯
• 其他的

干眼症治疗市场规模（依产品划分）

• 市场概况
• 人工泪液
• Cyclosporine
• 局部皮质类固醇
• 泪点塞
  • 可拆卸的
  • 溶解度
• 口服欧米茄补充剂
• 其他的

干眼症治疗市场规模（以剂型）

• 市场概况
• 眼药水/溶液
• 软膏和凝胶
• 胶囊和药片（用于补充剂）
• 其他剂型

干眼症治疗市场规模（依销售管道）

• 市场概况
• 处方笺
• 在商店
• 其他的

干眼症治疗市场规模（依分销管道划分）

• 市场概况
• 零售药局
• 医院药房
• 网路药局

干眼症治疗市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Novartis AG（Switzerland）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Santen Pharmaceutical Co. Ltd.（Japan）
• AFT Pharmaceuticals（New Zealand）
• Johnson & Johnson Services, Inc.（USA）
• Otsuka Pharmaceutical Co. Ltd.（Japan）
• OASIS Medical（USA）
• Bausch Health Companies Inc.（Canada）
• Alcon Inc.（Switzerland）
• Akorn Operating Company LLC（USA）
• Alimera Sciences（USA）
• GlaxoSmithKline plc（UK）
• Nicox SA（France）
• Novaliq GmbH（Germany）
• Horus Pharma（France）
• Mitotech（Russia）
• Prestige Consumer Healthcare（USA）
• Sentiss Pharma Pvt. Ltd.（India）
• VISUfarma（Netherlands）

结论和建议

Global Dry Eye Syndrome Treatment Market size was valued at USD 7.07 billion in 2023 and is poised to grow from USD 7.56 billion in 2024 to USD 13.0 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The global dry eye syndrome treatment market is experiencing robust growth, driven by the rising prevalence of the condition and an aging population. Increased awareness, coupled with technological advancements in diagnostic tools, and a focus on patient comfort, are propelling market expansion. The primary treatment options remain pharmaceutical interventions, such as artificial tears, anti-inflammatory drugs, and immunomodulators. Additionally, there's a growing trend towards innovative therapies, including regenerative medicine and gene therapy, which hold promise for addressing the root causes of dry eye syndrome. As research and development efforts intensify, the market is poised for continued growth, enhancing treatment efficacy and improving patient outcomes in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dry Eye Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dry Eye Syndrome Treatment Market Segmental Analysis

Global Dry Eye Syndrome Treatment Market is segmented by Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel and region. Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drugs, the market is segmented into Xiidra, Restasis, Cequa, Tyrvaya, Eysuvis and Others. Based on Product, the market is segmented into Artificial Tears, Cyclosporine, Topical Corticosteroids, Punctal Plugs, Oral Omega Supplements and Others. Based on Dosage Form, the market is segmented into Eye Drops/ Solutions, Ointments and Gels, Capsules & Tablets (For Supplements) and Other Dosage Forms. Based on Sales Channel, the market is segmented into Prescription, OTC and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market is experiencing significant growth driven by several factors contributing to the rising incidence of dry eye syndrome (DES) worldwide. Increased screen time associated with digital technology usage, an aging population, environmental pollution, and changing lifestyles have all significantly heightened the occurrence of DES. Consequently, this has led to a surge in demand for effective and innovative treatment solutions such as artificial tears, anti-inflammatory medications, and punctal plugs. This growing awareness and need for advanced therapeutic options are crucial in facilitating the expansion of the dry eye syndrome treatment market on a global scale.

Restraints in the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market faces a significant challenge due to the absence of a universal treatment solution. This condition is multifaceted, with various underlying causes such as aqueous deficiency and evaporative dysfunction, which results in a wide disparity in treatment effectiveness among patients. This variability often leads to extensive trial and error for individuals, causing frustration and delays in achieving relief. Furthermore, the complexity of dry eye syndrome complicates the pharmaceutical industry's efforts to create new therapies tailored to the distinct needs of each patient, ultimately hindering the potential growth of the market.

Market Trends of the Global Dry Eye Syndrome Treatment Market

The Global Dry Eye Syndrome Treatment market is increasingly shifting towards preservative-free eye drops and artificial tears, driven by a heightened awareness of the adverse effects associated with conventional preservatives. This trend reflects a broader consumer demand for safer, more effective therapeutic options that minimize irritation and enhance comfort for patients suffering from this chronic condition. As a result, pharmaceutical companies are investing in the development of innovative preservative-free formulations, aligning with patient preferences and regulatory pushes for safer healthcare products. Additionally, this trend is bolstered by the rising incidence of dry eye syndrome due to lifestyle factors, creating a robust market opportunity.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Trade Analysis

Global Dry Eye Syndrome Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Evaporative Dry Eye Syndrome
• Aqueous Deficient Dry Eye Syndrome

Global Dry Eye Syndrome Treatment Market Size by Drugs & CAGR (2025-2032)

• Market Overview
• Xiidra
• Restasis
• Cequa
• Tyrvaya
• Eysuvis
• Others

Global Dry Eye Syndrome Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Artificial Tears
• Cyclosporine
• Topical Corticosteroids
• Punctal Plugs
  • Removable
  • Dissolvable
• Oral Omega Supplements
• Others

Global Dry Eye Syndrome Treatment Market Size by Dosage Form & CAGR (2025-2032)

• Market Overview
• Eye Drops/ Solutions
• Ointments and Gels
• Capsules & Tablets (For Supplements)
• Other Dosage Forms

Global Dry Eye Syndrome Treatment Market Size by Sales Channel & CAGR (2025-2032)

• Market Overview
• Prescription
• OTC
• Others

Global Dry Eye Syndrome Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Dry Eye Syndrome Treatment Market Size & CAGR (2025-2032)

• North America (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • US
  • Canada
• Europe (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AFT Pharmaceuticals (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akorn Operating Company LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alimera Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nicox S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novaliq GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horus Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitotech (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sentiss Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VISUfarma (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations